Profile | GDS4284 / 210676_x_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 1614.76 | 81 |
GSM687648 | Patient 402 control | 3572.6 | 90 |
GSM687653 | Patient 403 control | 1810.5 | 83 |
GSM687658 | Patient 404 control | 1909.27 | 83 |
GSM687663 | Patient 411 control | 5941.66 | 95 |
GSM687668 | Patient 422 control | 2260.63 | 85 |
GSM687673 | Patient 424 control | 4252.74 | 92 |
GSM687678 | Patient 425 control | 948.484 | 72 |
GSM687683 | Patient 427 control | 4766.73 | 93 |
GSM687688 | Patient 428 control | 3546.62 | 90 |
GSM687695 | Patient 441 control | 794.478 | 71 |
GSM687699 | Patient 443 control | 841.755 | 71 |
GSM687704 | Patient 444 control | 1534.62 | 80 |
GSM687707 | Patient 448 control | 5441.47 | 94 |
GSM687712 | Patient 449 control | 1698 | 82 |
GSM687719 | Patient 450 control | 1372.05 | 79 |
GSM687724 | Patient 451 control | 5218.55 | 94 |
GSM687728 | Patient 452 control | 1755.16 | 82 |
GSM687646 | Patient 401 treated 24h | 1597.07 | 80 |
GSM687649 | Patient 402 treated 24h | 3950.72 | 91 |
GSM687665 | Patient 411 treated 24h | 5109.69 | 94 |
GSM687651 | Patient 402 treated 4 weeks | 3970.79 | 92 |
GSM687667 | Patient 411 treated 4 weeks | 5895.84 | 95 |
GSM687670 | Patient 422 treated 24h | 2199.16 | 85 |
GSM687671 | Patient 422 treated 4 weeks | 2528.31 | 87 |
GSM687654 | Patient 403 treated 24h | 1697.79 | 82 |
GSM687675 | Patient 424 treated 24h | 4254.13 | 92 |
GSM687685 | Patient 427 treated 24h | 4207.08 | 92 |
GSM687656 | Patient 403 treated 4 weeks | 1912.95 | 83 |
GSM687677 | Patient 424 treated 4 weeks | 3914.5 | 91 |
GSM687687 | Patient 427 treated 4 weeks | 5024.46 | 93 |
GSM687692 | Patient 428 treated 4h | 4066.35 | 92 |
GSM687716 | Patient 449 treated 4h | 1774.65 | 82 |
GSM687722 | Patient 450 treated 4h | 1401.11 | 79 |
GSM687680 | Patient 425 treated 24h | 805.763 | 71 |
GSM687690 | Patient 428 treated 24h | 3070.64 | 89 |
GSM687700 | Patient 443 treated 24h | 1228.37 | 77 |
GSM687705 | Patient 444 treated 24h | 1325.23 | 78 |
GSM687714 | Patient 449 treated 24h | 2073.43 | 84 |
GSM687721 | Patient 450 treated 24h | 1320.91 | 78 |
GSM687682 | Patient 425 treated 4 weeks | 574.578 | 66 |
GSM687694 | Patient 428 treated 4 weeks | 4193.69 | 92 |
GSM687702 | Patient 443 treated 4 weeks | 1492.5 | 80 |
GSM687718 | Patient 449 treated 4 weeks | 1675.79 | 82 |
GSM687723 | Patient 450 treated 4 weeks | 1389.38 | 79 |
GSM687661 | Patient 404 treated 4h | 2131.48 | 85 |
GSM687710 | Patient 448 treated 4h | 5472.62 | 94 |
GSM687726 | Patient 451 treated 4h | 5620.44 | 94 |
GSM687730 | Patient 452 treated 4h | 2544.42 | 88 |
GSM687660 | Patient 404 treated 24h | 1057.86 | 77 |
GSM687697 | Patient 441 treated 24h | 1401.01 | 80 |
GSM687709 | Patient 448 treated 24h | 5272.45 | 94 |
GSM687725 | Patient 451 treated 24h | 5096.03 | 94 |
GSM687729 | Patient 452 treated 24h | 1266.03 | 79 |
GSM687727 | Patient 451 treated 4 weeks | 5068.31 | 94 |
GSM687731 | Patient 452 treated 4 weeks | 1824.45 | 83 |